Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1656 in Renal Transplant with Type 2 Diabetes
NCT05216172Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Dec 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD1656 in type 2 diabetes mellitus (T2DM), kidney transplant rejection, sponsored by Queen Mary University of London. Started Dec 2019; status: completed.
02
Drugs
AZD1656
03
Conditions
type 2 diabetes mellitus (T2DM)kidney transplant rejection
Beyond the preview
Go deeper on NCT05216172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05216172.